Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks Mixed, IAG Drops Despite Guidance Upgraded

Fri, 30th Oct 2015 08:31

LONDON (Alliance News) - Stocks in London opened mixed Friday, with IAG as the worst blue-chip performer even though it reported a rise in operating profit in the third quarter and upgraded its profit guidance for 2015.

The FTSE 100 index opened down 0.1% at 6,389.83 points, the FTSE 250 was flat at 17,108.13, while the AIM All-Share was up 0.1% at 741.28. In Europe, the CAC 40 in Paris was up up 0.5% and the DAX 30 in Frankfurt was up 0.4%.

International Consolidated Airlines Group, which on Thursday approved its first dividend payment since it was created in 2011, said its operating profit in the third quarter to the end of September was EUR1.25 billion, up from EUR900.0 million a year earlier and still up to EUR1.21 billion when excluding the contribution from Aer Lingus Group, the Irish flag carrier IAG acquired this year.

For the nine months to the end of September, operating profit for the group was up to EUR1.77 billion from EUR1.05 billion a year earlier, a 69% rise.

The strong results in the quarter meant IAG has upgraded its operating profit guidance for the full year to EUR2.25 billion to EUR2.30 billion, a firmer target than the previous guidance for profit to be in excess of EUR2.20 billion. The new guidance also excludes any contribution from Aer Lingus.

Shares in the British Airways and Iberia owner were down 4.6% at the open.

Meanwhile, Royal Bank of Scotland Group was down 1.1%. It reported improved third-quarter net profit, as it booked a big gain on the loss of control of Citizens, the US retail bank it is selling, but warned that the costs of restructuring and addressing past conduct and litigation are not about to go away.

The bank said it made a GBP952 million net profit in the three months to September 30, compared with GBP896 million in the corresponding quarter the prior year. That included a GBP1.15 billion gain on the loss of control of Citizens, and the bank also confirmed that it is set to sell its remaining 20.9% stake in that bank.

Citizens Financial Group on Thursday said that RBS is now expected to exit its remaining 20.9% stake in the US retail bank. According to Citizens, RBS has launched a registered underwritten public offering to sell all of its remaining 110.5 million shares in the bank. RBS had previously set out plans to divest the rest of its stake by the end of 2015.

RBS peer Barclays was down 0.9% after several price target cuts from JPMorgan, Goldman Sachs, Exane BNP and Societe Generale. The bank closed Thursday as the biggest faller after it missed market expectations and cut guidance for 2016, as its adjusted pretax profit fell in the third quarter.

In the FTSE 250, Vectura Group is the best performer, up 4.7%, after it said it has secured two milestone payments following an approval of an inhaler in the US and after hitting a development milestone in Europe.

It said the US Food and Drug Administration has approved the dual combination Utibron Neohaler and Seebri Neohaler products for the long-term treatment of patients with chronic obstructive pulmonary disease. The approval has triggered a USD22.5 million milestone payment to Vectura from Swiss pharmaceuticals giant Novartis, Vectura's partner on the product.

Separately, the group has been paid a USD750,000 cash milestone after a further development milestone was hit for its VR632 therapy in the European Union. VR632 is an asthma and COPD inhaled treatment therapy which users Vectura's dry powder inhaler and formulation technology.

Outside company news, the Bank of Japan said that its Monetary Policy Board, governed by Haruhiko Kuroda, decided by an 8-1 majority vote to keep its target of raising the monetary base at an annual pace of about JPY80 trillion. The bank also maintained its asset purchase program unchanged.

Some economists had hoped that the Bank of Japan would announce additional stimulus, as the domestic economy is still struggling with deflation and a fits-and-starts recovery. The yen firmed up in reaction to the decision and is currently trading at the upper 120-range against the dollar.

"The market response suggests markets content with the status quo and especially the option for more QE later as well as the BoJ's confidence in a growth turnaround," said Accendo Markets analyst Michael van Dulken.

"Not dissimilar to the hawkish Fed statement mid-week seeing the positive outlook on growth outweighing the prospect of higher rates on the horizon. Markets still like cheap money, but may be coming round to a return to preference for actual growth," van Dulken added.

The Japanese Nikkei 225 index closed Friday up 0.8%. In China, the Shanghai Composite finished down 0.1%, while the Hang Seng in Hong Kong ended down 0.8%.

Wall Street ended mostly lower Thursday, with the DJIA down 0.1%, the S&P 500 flat and the Nasdaq Composite down 0.4%.

Growth in US economic activity slowed in the third quarter, according to a report released by the Commerce Department on Thursday. The report said annualised real gross domestic product rose by 1.5% in the third quarter compared to the 3.9% jump seen in the second quarter. Economists had expected a 1.7% increase.

In the economic calendar Friday, eurozone inflation and unemployment are at 1000 GMT. In the US, personal consumption data is at 1230 GMT, the Chicago purchasing managers' index is at 1345 GMT, and the Reuters/Michigan consumer sentiment index is at 1400 GMT.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
3 Oct 2019 15:59

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
26 Sep 2019 15:43

Vectura Senior Independent Non-Executive Foden Leaves, Werner Replaces

Vectura Senior Independent Non-Executive Foden Leaves, Werner Replaces

Read more
24 Sep 2019 12:56

Tuesday broker round up

(Sharecast News) - TUI: UBS upgrades to neutral with a target price of 900p.

Read more
11 Sep 2019 13:12

Wednesday broker round-up

(Sharecast News) - Renew Holdings: Peel Hunt initiates at buy with a target price of 500p.

Read more
11 Sep 2019 09:31

BROKER RATINGS SUMMARY: HSBC Downgrades Shell To Hold From Buy

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:----------FTSE 100----------HSBC CUTS ROYAL DUTCH SHELL TO - BP

Read more
10 Sep 2019 10:17

Vectura Proposes Capital Return Amid "Strong" Interim Revenue Growth

(Alliance News) - Drug development firm Vectura Group PLC proposed a special dividend and buyback Tuesday after reporting revenue jumped on a strong inhaler performance with losses the six months

Read more
3 Sep 2019 16:17

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 4 September Oxford BiomedicaHalf Year ResultsDunelm GroupFull Year Year Income

Read more
17 Jul 2019 10:16

Vectura Confirms Annual Outlook; Plans GBP50 Million Shareholder Award

(Alliance News) - Vectura Group PLC on Wednesday confirmed its research & development investment priorities and proposed a GBP50 million capital return.The pharmaceutical company said a

Read more
17 Jul 2019 08:35

LONDON MARKET OPEN: Fresnillo, Johnson Matthey Help Pull FTSE 100 Down

(Alliance News) - Stocks began the day lower in London on Wednesday, with Fresnillo and Johnson Matthey failing to please investors, though there were a number of

Read more
10 Jun 2019 09:13

Vectura Chief Executive To Leave; Finance Head Named As Interim CEO

LONDON (Alliance News) - Vectura Group PLC on Monday said Chief Executive James Ward-Lilley will be stepping down at the end of June.Paul Fry, chief financial officer, will assume the role

Read more
10 Jun 2019 07:41

LONDON MARKET PRE-OPEN: Vectura And MJ Gleeson CEOs Leave

LONDON (Alliance News) - Stock prices in London are seen opening higher on Monday after US President Donald Trump suspended his plans for tariffs on Mexico, while hopes of lower US interest rates

Read more
29 May 2019 14:41

Vectura trading in line, mulling capital returns

(Sharecast News) - Vectura confirmed on Wednesday that its outlook remains in line with guidance for the full year as it said it was considering returning some capital to shareholders.

Read more
29 May 2019 13:44

Wednesday broker round-up

(Sharecast News) - Serco: RBC Capital Markets upgrades to outperform with a target price of 150p.

Read more
29 May 2019 10:01

Vectura Group On Track, Confident On Prospects For Rest Of 2019

LONDON (Alliance News) - Pharmaceutical firm Vectura Group PLC said at its annual general meeting Wednesday it is on track to meet full year guidance.In March, the firm reported a slightly

Read more
24 May 2019 09:35

Vectura Gets Milestone Payment On Novartis Submission Of Asthma Drug

LONDON (Alliance News) - Pharmaceutical company Vectura Group PLC said it is to receive a USD2.5 million milestone payment from Novartis AG relating to possible new asthma therapy filed a with EU

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.